Organic compounds -- part of the class 532-570 series inventions

20080108800 - Selective reduction of spinosyn factors et-j and et-l to spinetoram: Spinetoram is selectively produced in excellent yields by hydrogenating a mixture of 3′-O-ethyl spinosyn J and 3′-O-ethyl spinosyn L in a water miscible organic solvent using hydrogen gas and a heterogeneous catalyst.... Agent: Dow Agrosciences Llc

20080108804 - Method for modifying rnas and preparing dnas from rnas: A method is disclosed for the modification of an end of RNA molecules and the use of such modified RNA molecules in cDNA synthesis for the purpose of cloning, detection, sequencing, and amplification of parts of the RNAs, the entire RNAs, or any cDNAs derived from such modified RNAs. The... Agent: Foley And Lardner LLP Suite 500

20080108805 - Method for the hybridisation of nucleic acids: m

20080108801 - Lipophilic conjugated irna agents: The invention relates to iRNA agents, which preferably include a monomer in which the ribose moiety has been replaced by a moiety other than ribose. The inclusion of such a monomer can allow for modulation of a property of the iRNA agent into which it is incorporated, e.g., by using... Agent: Lowrie, Lando & Anastasi, LLP A2038

20080108802 - Functional and hyperfunctional sirna directed against bcl-2: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing Bcl-2.... Agent: Kalow & Springut LLP

20080108803 - Functional and hyperfunctional sirna directed against bcl-2: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing Bcl-2.... Agent: Kalow & Springut LLP

20080103295 - Process for the preparation of sucrose-6-ester by esterification in the presence of solid superacid catalyst: One embodiment of the present invention is a process of making sucrose-6-ester from sucrose by transesterification in the presence of a solid super acid catalyst such as SO42−—TiO2/Al2O3 or SO42−—TiO2. The sucrose-6-acetate is then chlorinated to afford sucralose-6-acetate, using BTC or thionyl chloride. Sucralose-6-acetate is converted into TPSGA for the... Agent: Perkins Coie LLP

20080103296 - Methods and apparati using single polymer analysis: The invention relates to methods for analyzing and characterizing single polymers such as nucleic acid molecules. In preferred embodiments, the single molecules are analyzed using single molecule detection and analysis systems.... Agent: Wolf Greenfield & Sacks, P.C.

20080103297 - Methods and devices for removal of organic molecules from biological mixtures using a hydrophilic solid support in a hydrophobic matrix: Methods and devices for removing small negatively charged molecules from a biological sample mixture that uses a solid-phase extraction material that includes a hydrophilic solid support at least partially embedded within a hydrophobic matrix.... Agent: 3m Innovative Properties Company

20080103298 - Process for the preparation of sucralose by the chlorination of sugar with triphosgene (btc): In one embodiment of the invention a method to prepare sucralose-6-acylate through chlorinating sucrose-6-acylater by BTC in the process of sucralose preparation is disclosed. In this embodiment a Vilsmeier reagent is firstly prepared below 0° C. by dissolving BTC in DMF or in component solvent, containing DMF, toluene, dichloroethane, chloroform... Agent: Perkins Coie LLP

20080097085 - Crystalline maltitol powder less prone to consolidation and method for production thereof: The crystalline maltitol powder less prone to consolidation is obtained by charging crystalline or powdery maltitol into a shelf type dryer, a tunnel-type dryer, a cylindrical container, or the like and subjecting the equipment or container to a treatment wherein an air having a temperature of 30 to 33° C.... Agent: King & Spalding

20080097086 - Process for preparing anti-tumor oligosaccharide material from chitosan: The present invention relates to a process for preparing chito-oligosaccharide material by the enzymatic hydrolysis of chitinous materials, such as chitin, chitosan, and squid pen. The results of cell experiment showed that the oligosaccharide material of the invention causes a decrease in survival rate of U937 cell (a human leukemia... Agent: Bacon & Thomas, PLLC

20080097088 - Expression elements: The invention relates to genetic elements capable of improving the levels of expression of operably-linked transcription units. In particular, said genetic elements are derived from the 5′ untranslated regions of ribosomal protein genes and may comprise a CpG island. Also provided are vectors and host cells comprising said genetic elements... Agent: Cozen O'connor, P.C.

20080097087 - Peg-functional nucleic acid conjugate: The invention provides a conjugate of functional oligonucleotide with poly(ethylene oxide), polyion complex of the conjugate with cationic polymer, and micelle thereof. The micelle improves stability of the oligonucleotide in animal cells and its specific bindability to target gene.... Agent: Wenderoth, Lind & Ponack, L.L.P.

20080097089 - Sirna targeting deubiqutination enzymes: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed... Agent: Kalow & Springut LLP

20080097090 - Functional and hyperfunctional sirna directed against bcl-2: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing Bcl-2.... Agent: Kalow & Springut LLP

20080097092 - Sirna targeting kinases: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed... Agent: Kalow & Springut LLP

20080097091 - Sirna targeting tnfalpha: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed... Agent: Kalow & Springut LLP

20080090998 - Genes and uses for plant improvement: Transgenic seed for crops with improved traits are provided by trait-improving recombinant DNA where plants grown from such transgenic seed exhibit one or more improved traits as compared to a control plant. Exemplary recombinant DNA expresses a succinate semialdehyde dehydrogenase.... Agent: Monsanto Company

20080090999 - Nucleotide and amino acid sequences from xenorhabdus and uses thereof: The invention provides isolated nucleotide sequences from Xenorhabdus nematophila species Xs86068, and, in particular, nucleotide sequences that encode insect inhibitory proteins, the insecticidal proteins, and compositions that comprise one or more of the insecticidal proteins for use in controlling insect infestation.... Agent: Arnold & Porter LLP Attn:IPDocketing Dept.

20080090997 - Sirna targeting complement component 3 (c3): Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed... Agent: Kalow & Springut LLP

20080091000 - Stress-inducible plant promoters: The present invention discloses and claims stress-inducible plant promoters, DNA constructs with such promoters, transgenic plants containing such promoters and DNA constructs, isolated DNAs encoding such promoters, and methods of making and using such promoters, DNA constructs, transgenic plants, and isolated DNAs.... Agent: Sonnenschein Nath & Rosenthal LLP

20080091001 - Functional and hyperfunctional sirna directed against bcl-2: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing Bcl-2.... Agent: Kalow & Springut LLP

20080091002 - Functional and hyperfunctional sirna directed against bcl-2: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing Bcl-2.... Agent: Kalow & Springut LLP

20080091003 - Functional and hyperfunctional sirna directed against bcl-2: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing Bcl-2.... Agent: Kalow & Springut LLP

20080091004 - Functional and hyperfunctional sirna directed against bcl-2: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing Bcl-2.... Agent: Kalow & Springut LLP

20080091005 - Modified nucleotides, methods for making and using same: Modified nucleotides are disclosed for use in single molecule sequencing, methods for making the modified nucleotides and method for using the modified nucleotides. Linkers for making the modified nucleotide are also disclosed.... Agent: Robert W Strozier, P.l.l.c

20080091006 - Nitrate ester cyclodextrin complexes: The invention relates to 1:1 complexes of organic nitrate esters with cyclodextrins, to the production of these complexes and to the use thereof in the field of coronary medicine.... Agent: Fulbright & Jaworski, LLP

20080091007 - Modified cellulose films: A hydroxypropyl methyl cellulose film comprises hydroxypropyl methyl cellulose plasticised with a plasticiser comprising a fruit acid or a salt or a fruit acid, preferably lactic acid. The film is safe for human consumption and finds use as a wall material of an ingestible delivery capsule, e.g. containing a dose... Agent: Mcdermott, Will & Emery LLP